KASID
Search
- Page Path
- HOME > Search
Brief Communication
- IBD
- Colonic oncostatin M expression evaluated by immunohistochemistry and infliximab therapy outcome in corticosteroid-refractory acute severe ulcerative colitis
- Jim O’Connell, Jayne Doherty, Amy Buckley, David Cormican, Cara Dunne, Karen Hartery, John Larkin, Finbar MacCarthy, Paul McCormick, Susan McKiernan, Brian Mehigan, Cian Muldoon, Ciara Ryan, Jacintha O’Sullivan, David Kevans
- Intest Res 2022;20(3):381-385. Published online March 11, 2022
- DOI: https://doi.org/10.5217/ir.2021.00073
-
PDF
Supplementary Material
PubReader
ePub -
Citations
Citations to this article as recorded by
- Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis
Yue Yang, Kan-Zuo Fu, Gu Pan
World Journal of Gastrointestinal Surgery.2024; 16(1): 228. CrossRef - Tryptanthrin Down-Regulates Oncostatin M by Targeting GM-CSF-Mediated PI3K-AKT-NF-κB Axis
Na-Ra Han, Hi-Joon Park, Seong-Gyu Ko, Phil-Dong Moon
Nutrients.2024; 16(23): 4109. CrossRef
- Role of Oncostatin M in the prognosis of inflammatory bowel disease: A meta-analysis
- 5,490 View
- 337 Download
- 2 Web of Science
- 2 Crossref
First
Prev
